Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
07:17aMERCK : FDA Approves KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Combinat..
AQ
07/22MERCK : Eisai Win US FDA Approval of Keytruda Plus Lenvima Combination for Certa..
MT
07/22MERCK : FDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combin..
BU
07/21MERCK : Teams up with Noxxon to Evaluate NOX-A12 in Combination With Keytruda in..
MT
07/21MERCK : Secures European Approval for Verquvo for Chronic Heart Failure
MT
07/21MERCK : VERQUVO® (vericiguat) Approved in the European Union
BU
07/21European Commission (Ec) Grants Marketing Authorization in the European Union..
CI
07/21Merck Says Verquvo Granted Marketing Authorization in European Union
DJ
07/20MERCK : Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the Sa..
BU
07/20Merck Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the S..
CI
07/20Merck Posts Positive Safety Data for Investigational HIV Drug
DJ
07/19MERCK : Announces U.S. FDA Approval of VAXNEUVANCE (Pneumococcal 15-valent Conju..
AQ
07/19MERCK : Pneumonia Vaccine Gets FDA OK
MT
07/16MERCK : Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valen..
BU
07/16Merck Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-Valent Con..
CI
More most relevant news
All news about MERCK & CO., INC.
07:17aMERCK : FDA Approves KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Combinat..
AQ
07/22ADAGENE : Agrees With Merck on Trials of Its Monoclonal Antibodies With Keytruda..
MT
07/22MERCK : Eisai Win US FDA Approval of Keytruda Plus Lenvima Combination for Certa..
MT
07/22MERCK : FDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combin..
BU
07/21MERCK : Teams up with Noxxon to Evaluate NOX-A12 in Combination With Keytruda in..
MT
07/21BAYER : Heart Failure Treatment Wins EU Market Authorization
MT
07/21MERCK : Secures European Approval for Verquvo for Chronic Heart Failure
MT
07/21MERCK : VERQUVO® (vericiguat) Approved in the European Union
BU
07/21European Commission (Ec) Grants Marketing Authorization in the European Union..
CI
07/21Merck Says Verquvo Granted Marketing Authorization in European Union
DJ
More news
News in other languages on MERCK & CO., INC.
07/22MERCK : la FDA approuve un nouveau traitement
07/21MERCK : le Verquvo autorisé dans le marché européen
07/21Bayer-Herzmedikament Verquvo in der EU zugelassen
07/20MERCK : des nouvelles données sur l'islatravir pour le VIH
07/12MERCK : résultats prometteurs pour le molnupiravir
07/12ERCK : résultats prometteurs pour le molnupiravir
07/06MERCK : la FDA approuve une nouvelle indication du Keytruda
07/02MERCK : retrait d'une indication pour Keytruda
06/29MERCK : la CE valide une nouvelle indication du Keytruda
06/29Mercks Keytruda erhält EU-Zulassung zur Behandlung von Speiseröhrenkrebs
More news
Analyst Recommendations on MERCK & CO., INC.
07/14MERCK : RBC Lifts Price Target on Merck to $80 From $75 Ahead of Q2 Results, Rei..
MT
06/09MERCK : JPMorgan Adjusts Merck's Price Target to $100 From $105, Maintains Overw..
MT
06/08MERCK : Price Target From RBC Cut to $75 From $77 to Reflect Organon Spinoff, Se..
MT
06/07MERCK : Truist Securities Adjusts Merck's Price Target to $93 From $96, Maintain..
MT
06/03MERCK : SVB Leerink Adjusts Merck & Co.'s Price Target to $99 from $102, Keeps O..
MT
More recommendations
Press releases
07:17aMERCK : FDA Approves KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Combinat..
AQ
07/22MERCK : FDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combin..
BU
07/21MERCK : VERQUVO® (vericiguat) Approved in the European Union
BU
07/20MERCK : Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the Sa..
BU
07/19MERCK : Announces U.S. FDA Approval of VAXNEUVANCE (Pneumococcal 15-valent Conju..
AQ
More press releases
Official Publications
05/25Dividends 
05/11Report 
05/06Report 
05/05SEC Filing 10Q-1 
04/29SEC Filing 8K 
04/291st quarter results 
Upcoming event on MERCK & CO., INC.